SUBSCRIBE
SUBSCRIBE

Catalent

NEWS
Policy
Cannabis-Based Drug Companies Hopeful Epidiolex Will Pave the Way for Future Approvals
Following the U.S. Drug Enforcement Agency’s rescheduling of GW Pharmaceuticals’ Epidiolex from a Schedule I to a Schedule V, other cannabis-based drug development companies believe there is momentum for their medications to gain regulatory approval.
October 2, 2018
 · 
2 min read
 · 
Alex Keown
Drug Development
Biohaven Reports Positive Early Clinical Trial Results for Anxiety Drug
Biohaven Pharma, headquartered in New Haven, Conn., announced positive data from a proof-of-concept trial for its BHV-0223 in social anxiety and public speaking anxiety disorders.
August 16, 2018
 · 
3 min read
 · 
Mark Terry
Tiny KalVista Explodes on $760 Million Deal With Drug Giant Merck & Co.
Business
Growing Catalent Takes Out Cook Pharmica in $950 Million Deal
September 19, 2017
 · 
2 min read
Job Trends
Catalent’s $34 Million Expansion to Create 100 New Jobs in Wisconsin
October 24, 2016
 · 
2 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Deals
New Jersey’s Catalent Jumps on Rumors of Lonza Group’s Takeover Bid
April 14, 2016
 · 
3 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Business
Catalent Looks to Expand Wisconsin Facility, Report Says
October 14, 2015
 · 
2 min read
Job Trends
Catalent Pharma Solutions’ $52 Million Expansion Brings Hundreds of New Jobs to Kentucky
April 16, 2015
 · 
3 min read
Load More
JOBS
IN THE PRESS
Business
Catalent Announces Third Quarter Fiscal Year 2017 Earnings Conference Webcast
April 18, 2017
 · 
1 min read
Business
NEMUS Bioscience And Catalent To Advance NB1222 Into Human Dosage Formulation Development
March 3, 2017
 · 
4 min read
Deals
Catalent Completes Accucaps Acquisition To Expand Softgel Development And Manufacturing Capabilities And Capacity
February 16, 2017
 · 
5 min read
Business
Catalent Reports Second Quarter Fiscal Year 2017 Results
February 7, 2017
 · 
1 min read
Business
Catalent Release: Company Announces Second Quarter Fiscal Year 2017 Earnings Conference Webcast
January 19, 2017
 · 
1 min read
Business
Catalent To Develop Softgel Capsules For Jupiter Orphan Therapeutics’s Leading Orphan Disease Candidates
January 9, 2017
 · 
3 min read
Pharm Country
Catalent Completes Repricing Of Credit Agreement
December 12, 2016
 · 
3 min read
Pharm Country
Catalent Announces Launch Of Private Offering Of $400 Million (U.S. Dollar Equivalent) Of Euro-Denominated Senior Unsecured Notes Due 2024
November 28, 2016
 · 
4 min read
Business
Catalent Reports First Quarter Fiscal Year 2017 Results
November 8, 2016
 · 
1 min read
Business
Catalent Appoints Uwe Röhrhoff To Its Board Of Directors
November 1, 2016
 · 
1 min read
Load More